CNS Flashcards
Drugs that block D2 receptors in vomiting center
- Metoclopramide - crosses BBB
- Domperidone - does not cross BBB + L-dopa
- Chlorpromazine and promethazine
Drugs that block D2 receptors in basal ganglia
- L-dopa
- Bromocriptine
Drugs that block D2 receptors in pituitary gland
- Bromocriptine
Classification of anti-psychotic drugs
Typical older generation drugs
مشينا الprom ولاقانا dro وthixene قالو لينا halo
1. Phenothiazine - chlorpromazine and promethazine
- zine chlorprom + prometh
2. Butyrophenones - haloperidol and droperidol
dro بقول ليك halo -peridol
3. Thioxanthene - thiothixene and chlorprothixene
thiothix + chlrorpro - thixene
Atypical newer drugs
ROC
1. Risperidone
2. Olanzapine
3. Clozapine - resistant cases
risperiodone and zapine zap the crazy patient
Therapeutic uses of antipsychotic drugs
- Schizophrenia and mania - immediate quotienting reaction; full effect 1-2 weeks later
- Prevent severe nausea and vomiting due to cancer chemotherapy and radiation treatment - chlorpromazine and promethazine
- Chlorpromazine
- Intractable hiccups
- Hypothermia as an anesthetic adjuvant
Chlorpromazine
1. Prevent nausea and vomiting
2. Intractable hiccups
3. Anesthetic adjuvant
Adverse effects of antipsychotic drugs
- Extrapyramidal manifestations / parkinsonism like syndrome older
Blocks D2 in basal ganglia
- Tremors
- Dystonia
- Dyskinesia - Neuroleptic malignant syndrome
Autonomic disturbance
- Hypertension
- Muscle rigidity
- Hyperthermia
- Sweating
- Convulsions
Serious complication 20% mortality rate - Autonomic disturbance
- Blocks α receptor - postural hypotension and sexual dysfunction
- Muscarinic block - atropine like action - Endocrine disturbance atypical
- Pituitary gland - hyperprolactinemia amenorrhea and gynecomastia
- Increased hunger - weight gain and diabetes (5HT2A receptors responsible for satiety) - Arrhythmia - sudden cardiac arrest
- Cholestatic jaundice especially chlorpromazine
- Agranulocytosis especially clozapine atypical
Parkinsonism
Progressive degenerative disorder of the nigrostiral pathway resulting in decreased dopamine (imbalance between dopamine inhibitory an dactelycholine excitatory) which manifests as
Motor manifestations
1. Muscle rigidity
2. Bradykinesia and shuffling gate
3. Tremors at rest
Non-motor manifestations 3Ds
1. Dementia
2. Depression
3. Disturbance of sleep
Risk factors
1. Age >60 (early onset dementia)
2. Head trauma
3. Insecticides
Classification of antiparkinsoian durgs
Dopaminergic drugs ↑ dopamine
1. L-dopa + tolcapone (COMT inhibotr) + selegiline (MAO B) + carbidopa
2. Bromocriptine (partial dopaine angonist بحل مكان الlevodpa)
3. Amandine (infuanzea A dopamine release)
Anti-cholinergic ↓ Ach
BOT
1. Benztropine (علي وزن atrophine)
2. Orphenadrine
3. Trihexyphenidyl
Levodopa - L-dopa
Pharmacokinetics
- Absorption - well absorbed from GIT; taken orally; take on an empty stomach leucine and isoleucine interfere with absorption
L L levodopa leucine
- Short half life 1-2 hrs → COMT tolcapone and MAO B inhibitors seligium
Short half life → on and off phenomenon
- >90 % of L-dopa decarboxylation in peripheral tissue → peripheral decraboxylase enzymes crabidopa and benserazide
Mechanism of action
L-dopa decarboxylation dopamine
Adverse effects
GIT 1
1. Vomiting center → nauseas and vomiting
CNS 2
2. Mesolimbic and mesocortical tract → mood changes, hallucination and nightmares
3. On-off phenomenon - sudden improvement followed by sudden immobility
4. Dyskinesia
Autonomic 3
5. Postural hypotension
Fenoldopam antihypertensive vasodilation D1 receptors
L-dopa
60% peripheral → D1 receptors → vasodilation
20% brain
6. Sympathomimetic → arrythmia + mydriasis increases IOP
7. Brown urine and sweat due to homovanillic acid metabolite
Interactions
DO NOT
1. Give on an empty stomach - interacts with leucine and isoleucine
2.Vitamin B6 pyridoxine ↑ peripheral decarboxylation
3. Antipsychotic drugs - decrease dopamine
GIVE
4. COMT inhibitor + MAO B inhibitor + peripheral decarboxylase inhibitor
COMT inhibitor
- Tolcapone
- Entacapone
Inhibits COMT enzyme reversibly to increase half-life
L-dopa → L-3-methyldopa in gut and liver
Side effects
1. Acute fulminant hepatitis acute liver failure
2. L-dopa - nauseas, vomiting hallucinations, mood swings
Selective MAO B inhibitor
- Selegiline
Inhibits dopamine breakdown in brain by MAO B
DOES NOT cause cheese reaction
- Cheese reaction happens in MAO A inhibitors in the liver they prevent tyramine breakdown (found in cheese) which enters the circulation and causes increased BP and acute hypertensive crisis
Side effects
1. Insomnia IS
2. L-dopa - nauseas, vomiting hallucinations, mood swings
Domapine agonists
- Bromocreptine
Ergot alkaloid
Can cross BBB and absorbed easilty
Advantages
Long half-life - do not need MAO or COMT inhibitors AND no on and off phenomenon
Side effects
1. Pulmonary fibrosis
2. L-dopa - nauseas, vomiting hallucinations, mood swings, postural hypotension
Dopamine release
- Amantadine
Uses
1. Infulenza A
2. Antiparkinsoin
Mechanism of action
1. Increases dopamine release
2. Decreases dopamine reputpake
3. Direct effect on dopamine receptors
Side effects
1. Levido reticularis - skin pigmentation/moltted skin
2. L-dopa - nauseas, vomiting hallucinations, mood swings
Anticholingeric drugs
BOT
1. Benztropine
2. Orphenadrine
3. Trihexyphenidyl
Blocks M1 central receptors
Effects
1. Improvement of tremor
2. Prevent sialorrhea
3. Control acute drug induced extrapyramidal manifestations
Side effects
1. Dementia
2. Urine retention especially with BPH
3. Narrow angle glaucoma
SAD HC
زغلوله االناشفه حبست جوزها ابو سريعه
Depression
Mood distrubance
Pathophysiology
1. Genetics - 4 genes
2. Biogenic amine and receptor theory
- ↓ NA ↓ serotonin ↓ dopamine
- Upregulation of 5HT2A and 5HT2c receptors
3. Neurotrophic and cytokine theory
- ↓ BDNF (brain derived neurotrophic factor)
- Hypothalamic-pituitary axis dysfunction
- Proinflammatory cytokines IL1, IL6 and TNF
Types of depression
1. Unipolar - MDD major depressive disorder constant low levels
2. Bipolar - Manic depressive depression high and low levels
Mood stabilizer
Symptoms
Emotional serotonin
1. Anhedonia
2. Apathy and low self esteem
3. Loss of motivation
Psychosomatic/biologic NA
1. Chronic pain
2. Sleep disturbance
3. Loss of appetite and libido (does not want to eat)
Classification of antidepressant drugs
- MAOIs - Selegiline, phenelzine, tranylcypromine, Moclobemide
TPS - TCAs - Imipramine, Desipramine, Clomipramine, Amitriptyline, Nortriptyline
- pramine imi, desi and clomi
- triptyline ami and nor - SSRIs - Fluoxetine, Paroxetine, Sertraline MI, Citalopram, Escetalopram
- oxetine flu and par
- line sertra
- lopram cita and esceta - Atypical heterocyclic antidepressants - venlafaxine, duloxetine, trazodone and mirtazapine